Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Feb 05, 2008

Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007

Feb 01, 2008

Mylan Announces Final FDA Approval for Granisetron Hydrochloride Tablets

Jan 30, 2008

Mylan Declares Quarterly Preferred Stock Dividend

Jan 25, 2008

Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation

Dec 31, 2007

Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules

Dec 28, 2007

Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets

Dec 21, 2007

Mylan Sets Date of 2008 Annual Meeting

Dec 12, 2007

Mylan Inc. Announces Tentative FDA Approval for Lamotrigine Tablets

Dec 06, 2007

Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock

Dec 04, 2007

Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets

Pagination

First page
Previous page
…
Page 93
Page 94
Page 95
Page 96
Current page 97
Page 98
Page 99
Page 100
Page 101
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.